Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2011-06-27Clinical Trial Update: A Retrospective EGFR Mutation Status Study in Chinese NSCLC Patients Using Paired Plasma and Tissue Samples
A retrospective study in Chinese non-small cell lung cancer patients examines EGFR mutation status using paired plasma and tissue samples.
-
CLINICAL_TRIALS trial_result · 2011-06-23Clinical Trial Update: An Open, Randomized, Multicentre, Phase II Pilot Study [Phase 2]
An open, randomized, multicentre Phase II pilot trial in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-22Clinical Trial Update: A Study of Bevacizumab in Combination With First- or Second-Line Therapy in Subjects With Treated Brain Metastases Due to Non-Squamous NSCLC (PASSPORT) [Phase 2]
Phase 2 trial assessing bevacizumab combined with first- or second-line therapy in patients with treated brain metastases from non-squamous …
-
CLINICAL_TRIALS research · 2011-06-16Clinical Trial Update: Pathomolecular Analysis of Rare EGFR Mutations in Advanced NSCLC
Clinical trial update detailing pathomolecular analysis of rare EGFR mutations in advanced non-small cell lung cancer. The study status is l…
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: A Study In Patients With Non-Small Cell Lung Cancer Testing If Erlotinib Plus SU011248 (Sunitinib) Is Better Than Erlotinib Alone [Phase 2]
Phase 2 trial in non-small cell lung cancer evaluating whether adding SU011248 (sunitinib) to erlotinib improves outcomes over erlotinib alo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-06-09Clinical Trial Update: Study of Salirasib to Treat Non-Small Cell Lung Cancer [Phase 2]
The document reports the completion of a Phase 2 clinical trial evaluating salirasib for non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2011-06-07Clinical Trial Update: A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC [Phase 2]
This is a Phase 2 trial evaluating cetuximab and bevacizumab in combination with paclitaxel and carboplatin for stage IIIb/IV non-small cell…
-
CLINICAL_TRIALS trial_result · 2011-06-03Clinical Trial Update: Tarceva Surgery for Resectable Stage IIIA(N2) and IIIB (T4 N2) Non-Small-Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluated Tarceva (erlotinib) as surgical adjuvant therapy for resectable stage IIIA(N2) and IIIB NSCLC; the study was termi…
-
CLINICAL_TRIALS trial_result · 2011-06-01Clinical Trial Update: Phase I/II Study of AZD2171 in Combination With Paclitaxel/Carboplatin in Japanese Non-Small Cell Lung Cancer Patients [Phase 1]
Phase I/II study evaluating AZD2171 in combination with paclitaxel and carboplatin in Japanese patients with non-small cell lung cancer; the…
-
CLINICAL_TRIALS trial_result · 2011-05-30Clinical Trial Update: A Phase II Study of ACZONE™ (Dapsone) Gel, 5% As a Treatment For Tarceva® (Erlotinib)Related Rash [Phase 2]
Phase II study evaluating 5% dapsone gel (ACZONE) to treat erlotinib-related rash in patients with non-small cell lung cancer; the trial was…
-
CLINICAL_TRIALS trial_result · 2011-05-24Clinical Trial Update: Efficacy Trial Comparing ZD6474 With Erlotinib in NSCLC After Failure of at Least One Prior Chemotherapy [Phase 3]
Phase 3 trial comparing ZD6474 with erlotinib in non-small cell lung cancer after prior chemotherapy.
-
CLINICAL_TRIALS trial_result · 2011-05-24Clinical Trial Update: ZACTIMA (an Anti-EGFR / Anti-VEGF Agent) Combined With Docetaxel Compared to Docetaxel in Non-small Cell Lung Cancer [Phase 3]
Phase 3 trial evaluating ZACTIMA (vandetanib) plus docetaxel versus docetaxel alone in non-small cell lung cancer has completed with results…
-
CLINICAL_TRIALS trial_result · 2011-05-23Clinical Trial Update: Induction Gemcitabine & Carboplatin Followed by Paclitaxel & Carboplatin +XRT in NSCLC [Phase 2]
This Phase 2 trial assesses induction gemcitabine and carboplatin followed by paclitaxel and carboplatin with radiation therapy in non-small…
-
CLINICAL_TRIALS trial_result · 2011-05-23Clinical Trial Update: Irinotecan Plus Cisplatin vs Pemetrexed Plus Cisplatin as 2nd Line in NSCLC Stage IIIB/IV [Phase 2]
Phase 2 trial comparing Irinotecan plus Cisplatin versus Pemetrexed plus Cisplatin as second-line therapy in advanced non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2011-05-20Clinical Trial Update: Iressa vs Placebo as Maintenance Therapy in Locally Advanced NSCLC [Phase 3]
Phase 3 trial evaluating Iressa (gefitinib) vs placebo as maintenance therapy in locally advanced non-small cell lung cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: Trial of Neoadjuvant Docetaxel and Cisplatin for Resectable Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial of neoadjuvant docetaxel plus cisplatin for resectable non-small cell lung cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: Cerebrospinal Fluid Levels of Erlotinib in Patients Receiving Erlotinib For Stage III Non-Small Cell Lung Cancer [NA]
Clinical trial update reporting cerebrospinal fluid levels of erlotinib in patients with stage III non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2011-05-13Clinical Trial Update: Iressa Versus Docetaxel (Taxotere) [Phase 3]
Phase 3 trial comparing gefitinib (Iressa) with docetaxel (Taxotere) for non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-03Clinical Trial Update: Iressa in Poor Performance Status Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial update of Iressa (gefitinib) in patients with poor performance status and previously untreated advanced non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2011-04-25Clinical Trial Update: Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase II trial evaluating weekly paclitaxel (BMS-181339) in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2011-04-22Clinical Trial Update: Erlotinib vs. Standard Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) and Eastern Cooperative Oncology Group (ECOG)Performance Status (PS) 2 [Phase 2]
Phase 2 trial comparing erlotinib to standard chemotherapy in patients with advanced non-small cell lung cancer and ECOG performance status …
-
CLINICAL_TRIALS trial_result · 2011-04-20Clinical Trial Update: Pemetrexed &Oxaliplatin in Patients w Recurrent NSCLCa After Failure to Platinum Based Adjuvant Chem [Phase 2]
Phase 2 trial evaluating pemetrexed in combination with oxaliplatin for recurrent non-small cell lung cancer after platinum-based adjuvant f…
-
CLINICAL_TRIALS trial_result · 2011-04-15Clinical Trial Update: Ixabepilone in Combination With Carboplatin in Patients With Non-small Cell Lung Cancer [Phase 1]
Phase 1 trial evaluating the safety and preliminary efficacy of ixabepilone in combination with carboplatin in patients with non-small cell …
-
CLINICAL_TRIALS trial_result · 2011-04-15Clinical Trial Update: Hormone Changes in Women With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Receiving Erlotinib
This completed clinical trial updates hormone changes observed in women with Stage IIIB or Stage IV non-small cell lung cancer treated with …
-
CLINICAL_TRIALS research · 2011-04-15Clinical Trial Update: Maintenance Gemcitabine in the Chinese Advanced Lung Cancer [Phase 4]
Phase 4 maintenance trial of gemcitabine for non-small cell lung cancer in Chinese patients, with the trial status currently unknown.